NCT05277935View on ClinicalTrials.gov

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Breast Neoplasm FemaleQuality of Life
Interventions
DEVICE

Use of the WeCancer app combined with the smartwatch.

To evaluate if a fitness tracker added to eHealth technology will improve quality of life compared to the use of eHealth technology alone in metastasis breast cancer patients treated with palbociclib and endocrine therapy

Trial Locations (4)

Unknown

RECRUITING

Oncoclínicas, Rio de Janeiro

RECRUITING

A Beneficência Portuguesa de São Paulo, São Paulo

RECRUITING

A.C.Camargo Cancer Center, São Paulo

RECRUITING

Centro Paulista de Oncologia, São Paulo

All Listed Sponsors
lead

Beneficência Portuguesa de São Paulo

OTHER